APA

Jagadeeswaran R., Vazquez B. A., Thiruppathi M., Ganesh B. B., Ibanez V., Cui S., Engel J. D., Diamond A. M., Molokie R. E., DeSimone J., Lavelle D. & Rivers A. (20170926). Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell disease. : Experimental hematology.

Chicago

Jagadeeswaran Ramasamy, Vazquez Benjamin A, Thiruppathi Muthusamy, Ganesh Balaji B, Ibanez Vinzon, Cui Shuaiying, Engel James D, Diamond Alan M, Molokie Robert E, DeSimone Joseph, Lavelle Donald and Rivers Angela. 20170926. Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell disease. : Experimental hematology.

Harvard

Jagadeeswaran R., Vazquez B. A., Thiruppathi M., Ganesh B. B., Ibanez V., Cui S., Engel J. D., Diamond A. M., Molokie R. E., DeSimone J., Lavelle D. and Rivers A. (20170926). Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell disease. : Experimental hematology.

MLA

Jagadeeswaran Ramasamy, Vazquez Benjamin A, Thiruppathi Muthusamy, Ganesh Balaji B, Ibanez Vinzon, Cui Shuaiying, Engel James D, Diamond Alan M, Molokie Robert E, DeSimone Joseph, Lavelle Donald and Rivers Angela. Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell disease. : Experimental hematology. 20170926.